VKTX
Viking Therapeutics, Inc.Healthcare$34.80
▲ Bullish
Mkt Cap: $4.02B|Float: 112.7M|SI: 21.6%|DTC: 9.6
Data as of market close Apr 2, 2026
IV Rank
0
IV Pctl
0%
HV 20d
61.9%
52W Range
$19-$43
ATR(14)
$2.07
Exp. Move
±8.3%
P/C Ratio
0.19
Earnings
Apr 29
GEX Positive
DEX Long
Net Call Premium
IV Low
Max Pain Below
Exp. Move Wide
Low Put/Call
VKTX Key Options Data
- IV Rank
- 0%
- Total GEX
- $0.01B
- Total DEX
- $5.2M
- Max Pain
- $33.00
- Expected Move
- ±8.3%
- Put/Call OI
- 0.19
- Net Premium
- $2.2M
- Spot Price
- $34.80
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$2.88 | ±8.3% | $31.92 | $37.68 |
| 2026-04-17 | 15 | ±$4.06 | ±11.7% | $30.74 | $38.86 |
| 2026-04-24 | 22 | ±$5.71 | ±16.4% | $29.09 | $40.51 |
| 2026-05-01 | 29 | ±$2.92 | ±8.4% | $31.87 | $37.72 |
| 2026-05-08 | 36 | ±$3.17 | ±9.1% | $31.63 | $37.96 |
| 2026-05-15 | 43 | ±$7.53 | ±21.6% | $27.27 | $42.32 |
Explore VKTX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.